Brief: 10X Genomics Q2 Revenue USD 146.8 Million Vs. IBES Estimate USD 140 Million
03/08/2023 21:05
Aug 03 (Reuters) - 10X Genomics Q2 operating income USD -63.4 million. * Q2 gross margin 68% * Q2 net income USD -62.4 million * Outlook FY Revenue USD 600-620 Million
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences